| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.0B | $0.0B | $-0.0B | $0.1B | $0.0B | $-0.0B | $0.0B | — |
| EPS (Basic) | — | — | — | — | — | — | — | — |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $0.1B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | — |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | $0.0B | $0.0B | — |
| Total Liabilities | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | — |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.1B | — | $0.1B | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | — | — | $0.0B | $-0.0B | $0.0B | $-0.0B | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | — | — | $0.0B | $0.0B | $-0.0B | $0.0B | — |